Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy

2021 ◽  
Vol 96 ◽  
pp. 107714
Author(s):  
Na Qu ◽  
Yiming Meng ◽  
Mike K. Handley ◽  
Chunyan Wang ◽  
Fengping Shan
2018 ◽  
Vol 14 (2) ◽  
pp. 177-180 ◽  
Author(s):  
Samy K Metyas ◽  
Christina L. Chen ◽  
Karen Yeter ◽  
John Solyman ◽  
Daniel Arkfeld
Keyword(s):  
Low Dose ◽  

Sign in / Sign up

Export Citation Format

Share Document